Synchronous colorectal liver metastases: Is it time to reconsider traditional paradigms of management?

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2395-2410

  Reddy, Srinevas K ^a   Barbas, Andrew S ^a   Clary, Bryan M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONSERVATIVE TREATMENT; HUMAN; LIVER METASTASIS; LIVER RESECTION; MORBIDITY; PREOPERATIVE PERIOD; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 68949201542     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0372-1     Document Type: Review

References (162)

1. N Chafai CLH Chan EL Bokey et al 2005 What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis 7 176 181
2. P Rougier C Milan F Lazorthes et al 1995 Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer Br J Surg 82 1397 1400
3. R Stangl A Altendorf-Hofmann RM Charnley et al 1994 Factors influencing the natural history of colorectal liver metastases Lancet 343 1405 1410
4. Al-asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal liver metastases. Cochrane Database Syst Rev. 2008;CD006039.
5. Cummings FJ, Varker K, Begossi G, et al. Hepatic artery infusion in surgical therapy of hepatic metastases from colorectal cancer. J Clin Oncol. 2008;26:abstr 15077.
6. JS Tomlinson WR Jarnagin RP DeMatteo et al 2008 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 4575 4580
7. RC Newland OF Dent PH Chapuis et al 1993 Clinicopathologically diagnosed residual tumour after resection for colorectal cancer: a 20-year prospective study Cancer 72 1536 1542
8. L Vigano A Ferrero RL Tesoriere et al 2008 Liver surgery for colorectal metastases: results after 10 years of follow-up, long-term survivors, late recurrences, and prognostic role of morbidity Ann Surg Oncol 15 2458 2464
9. TM Pawlik CR Scoggins D Zorzi et al 2005 Effect of surgical margin status on survival and site of recurrence after hepatic resection of colorectal metastases Ann Surg 241 715 724
10. G Portier D Elias O Bouche et al 2006 Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 Trial J Clin Oncol 24 4976 4982
11. TA Aloia JN Vauthey EM Loyer et al 2006 Solitary colorectal liver metastasis: resection determined outcome Arch Surg 141 460 466
12. C Charnsangavej B Clary Y Fong et al 2006 Selection of patients for resection of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol 13 1261 1268
13. TM Pawlik RD Schulick MA Choti 2008 Expanding criteria for resectability of colorectal liver metastases Oncologist 13 51 64
14. R Adam V Delvart G Pascal et al 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy Ann Surg 240 644 658
15. JG Fortner JS Silva EB Cox et al 1984 Multivariate of a personal series of 247 patients with liver metastases from colorectal cancer Ann Surg 199 317 324
16. T Yamamura T Senda O Akaishi et al 1990 Comparative studies on treatment for liver metastases from colorectal cancer St Marianna Med J 18 501 508
17. D Cady DO Monson NW Swinton 1970 Survival of patients after colonic resection for carcinoma with simultaneous liver metastases Surg Gynecol Obstet 131 697 700
18. LH Blumgart DJ Allison 1982 Resection and embolization in the management of secondary hepatic tumors World J Surg 6 32 45
19. G Jatzko V Wette M Muller et al 1991 Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital Int J Colorectal Dis 6 111 114
20. M Minagawa J Yamamoto S Miwa et al 2006 Selection criteria for simultaneous resection in patients with synchronous liver metastasis Arch Surg 141 1006 1012
21. NC Tebutt AR Norman D Cunningham et al 2003 Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases Gut 52 568 573
22. CR Scoggins IM Meszoely CD Blanke et al 1999 Nonoperative management of primary colorectal cancer in patients with stage IV disease J Surg Oncol 6 651 657
23. S Benoist K Pautrat E Mitry et al 2005 Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 1155 1160
24. C Tournigand T Andre E Achille et al 2004 FOLFIRI followed by FOLFOX or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237
25. H Hurwitz L Fehrenbacher W Novotny et al 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342
26. JA Meyerhardt RJ Mayer 2005 Systemic therapy for colorectal cancer N Engl J Med 352 476 487
27. Rivera F, Van Cutsem E, Kretzschmar A, et al. Preliminary efficacy of bevacizumab with first-line FOLFOX, XELOX, FOLFIRI, and monotherapy for mCRC: first BEATrial. Ann Oncol. 2007;18:abstr O-0025.
28. Tirelli U, Berretta M, Di Benedetto F, et al. Presurgical chemotherapy with FOLFOX4-regimen for patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2008;26:abstr 15052.
29. Masi G, Loupakis F, Baldi G, et al. Outcome of initially unresectable metastatic colorectal cancer patients treated with first-line FOLFOXIRI followed by R0 surgical resection of metastases. J Clin Oncol. 2008;26:abstr 4074.
30. DA Wicherts RJ de Haas R Adam 2007 Bringing unresectable liver disease to resection with curative intent Eur J Surg Oncol 33 S42 51
31. C Pozzo M Basso A Cassano et al 2004 Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann Oncol 15 933 939
32. G Nuzzo F Giuliante F Ardito et al 2007 Liver resection for primary unresectable colorectal metastases downsized by chemotherapy J Gastrointest Surg 11 318 324
33. EK Abdalla R Adam AJ Bilchik et al 2006 Improving resectablity of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol 13 1271 1280
34. B Nordlinger E Van Cutsem P Rougier et al 2007 Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? Eur J Cancer 43 2037 2045
35. Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially irresectable colorectal liver metastases: is there a possibility of cure by an oncosurgical approach? J Clin Oncol. 2008;26:abstr 4081.
36. R Adam T Aloia F Levi et al 2007 Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy J Clin Oncol 25 4593 4602
37. Wagner AD, Arnold D, Grothey A, et al. Anti-angiogenic therapies for metastatic colorectal cancer: preliminary results of a systematic review and meta-analysis. J Clin Oncol. 2008;26:abstr 4060.
38. HS Hochster LL Hart RK Ramanathan et al 2008 Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE study J Clin Oncol 26 3523 3529
39. M Minagawa J Yamamoto T Kosuge et al 2007 Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation Arch Surg 142 269 276
40. M Minagawa M Makuuchi G Torzilli et al 2000 Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results Ann Surg 231 487 499
41. Y Fong J Fortner RL Sun et al 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309 321
42. B Nordlinger M Guiguet JC Vaillant et al 1996 Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients Cancer 77 1254 1262
43. M Schindl SJ Wigmore EJ Currie et al 2005 Prognostic scoring in colorectal cancer liver metastasis: development and validation Arch Surg 140 183 189
44. A Altendorf-Hofmann J Scheele 2003 A critical review of the major indicators of prognosis after resection of hepatic metastases form colorectal carcinoma Surg Oncol Clin N Am 12 165 192
45. T Mala G Bohler O Mathisen et al 2002 Hepatic resection for colorectal metastases: can preoperative scoring predict outcome? World J Surg 26 1348 1353
46. B van Ooijen T Wiggers S Meijer et al 1992 Hepatic resections for colorectal metastases in The Netherlands: a multi-institutional 10-year study Cancer 70 28 34
47. B Cady RL Jenkins GD Steele et al 1998 Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome Ann Surg 227 566 571
48. RL Jamison JH Donohue DM Nagorney et al 1997 Hepatic resection for metastatic colorectal cancer results in cure for some patients Arch Surg 132 505 511
49. K Hughes J Scheele PH Sugarbaker 1989 Surgery for colorectal cancer metastatic to the liver: optimizing the results of treatment Surg Clin N Am 69 339 359
50. KS Hughes RB Rosenstein S Songhorabodi et al 1988 Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors Dis Colon Rectum 31 1 4
51. LT Jenkins KW Millikan SD Bines et al 1997 Hepatic resection for metastatic colorectal cancer Am Surg 63 605 610
52. R Doci L Gennari P Bignami et al 1991 One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants Br J Surg 78 797 801
53. P Hohenberger PM Schlag T Gerneth et al 1994 Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases: predictive value and implications for adjuvant treatment based on multivariate analysis Ann Surg 219 135 143
54. Ychou M, Hohenberger W, Thezenas S, et al. Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU + irinotecan (LV5FU + IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). J Clin Oncol. 2008;26:abstr LBA4013.
55. Mariani P, Des Guetz G, Uzzan B, et al. Systemic or hepatic arterial chemotherapy after curative resection of liver metastases from colorectal cancer: a meta-analysis of randomized controlled trials. J Clin Oncol. 2008;26:abstr 4077.
56. S Iwatsuki I Dvorchik JR Madariaga et al 1999 Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system J Am Coll Surg 189 291 299
57. KE Harmon JA Ryan TR Biehl et al 1999 Benefits and safety of hepatic resection for colorectal metastases Am J Surg 177 402 404
58. J Harms T Obst S Thorban et al 1999 The role of surgery in the treatment of liver metastases for colorectal cancer patients Hepatogastroenterology 46 2321 2328
59. N Kokudo M Seki H Ohta et al 1998 Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases Ann Surg Oncol 5 706 712
60. M Bockhorn A Frilling NR Fruhauf et al 2008 Survival of patients with synchronous and metachronous colorectal liver metastases-is there a difference? J Gastrointest Surg 12 1399 1405
61. L Capussotti L Vigano A Ferrero et al 2007 Timing of resection of liver metastases synchronous to colorectal tumor: proposal for prognosis-based decisional model Ann Surg Oncol 14 1143 1150
62. WS Lee MJ Kim SH Yun et al 2008 Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis Langenbecks Arch Surg 393 13 19
63. E de Santibanes FB Lassalle L McCormack et al 2002 Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes J Am Coll Surg 195 196 202
64. Gruenberger T, Kaczirek K, Bergmann M, et al. Progression-free survival in a phase II study of perioperative bevacizumab plus XELOX in patients with potentially curable metastatic colorectal cancer. J Clin Oncol. 2008;26:abstr 4073.
65. S Jonas A Thelen C Benckert et al 2007 Extended resections of liver metastases from colorectal cancer World J Surg 31 511 521
66. J Figueras J Torras C Valls et al 2007 Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients Dis Colon Rectum 50 478 488
67. MS Tsai YH Su MC Ho et al 2007 Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis Ann Surg Oncol 14 786 794
68. AC Wei PD Greig D Grant et al 2006 Survival after hepatic resection for colorectal metastases: a 10-year experience Ann Surg Oncol 13 668 676
69. MA Choti JV Sitzmann MF Tiburi et al 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 759 766
70. HZ Malik ZZR Hamady R Adair et al 2007 Prognositic influence of multiple hepatic metastases from colorectal cancer Eur J Surg Oncol 33 468 473
71. G Ercolani GL Grazi M Ravaioli et al 2002 Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival Arch Surg 137 1187 1192
72. EA Bakalakos JA Kim DC Young et al 1998 Determinants of survival following hepatic resection for metastatic colorectal cancer World J Surg 22 399 405
73. B Ohlsson U Stenram KG Tranberg 1998 Resection of colorectal liver metastases: 25-year experience World J Surg 22 268 277
74. S Ambiru M Miyazaki T Isono et al 1999 Hepatic resection for colorectal metastases: analysis of prognostic factors Dis Colon Rectum 42 632 639
75. C Laurent AS Cunha P Couderc et al 2003 Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases Br J Surg 90 1131 1136
76. AL Bradley WC Chapman JK Wright et al 1999 Surgical experience with hepatic colorectal metastasis Am Surg 65 560 566
77. I Nagashima T Takada K Matsuda et al 2004 A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection J Hepatobiliary Pancreat Surg 11 79 83
78. N Nicoli A Casaril G Mangiante et al 2004 Surgical treatment for liver metastases from colorectal carcinoma: results of 228 patients Hepatogastroenterology 51 1810 1814
79. JK Seifert TC Bottger TF Weigel et al 2000 Prognostic factors following liver resection for hepatic metastases from colorectal cancer Hepatogastroenterology 47 239 246
80. K Tanaka H Shimada M Ueda et al 2007 Long-term characteristics of 5-year survivors after liver resection for colorectal metastases Ann Surg Oncol 14 1336 1346
81. R Parks M Gonen N Kemeny et al 2007 Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents J Am Coll Surg 204 753 763
82. B Nordlinger H Sorbye B Glemelius et al 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for respectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial Lancet 371 1007 1016
83. B Gruenberger Scheithauer R Punzengruber et al 2008 Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 120 127
84. I Taylor 2008 Adjuvant chemotherapy after resection of liver metastases from colorectal cancer Eur J Cancer 44 1198 1201
85. K Tanaka R Adam H Shimada et al 2003 Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 90 963 969
86. JC Hewes S Dighe RW Morris et al 2007 Preoperative chemotherapy and the outcome of liver resection for colorectal metastases World J Surg 31 353 364
87. PJ Allen N Kemeny W Jarnagin et al 2003 Importance of neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 109 115
88. G Mentha P Majno S Terraz et al 2007 Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour Eur J Surg Oncol 33 S76 S83
89. G Mentha PE Majno A Andres et al 2006 Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary Br J Surg 93 872 878
90. P Kornprat WR Jarnagin M Gonen et al 2007 Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy Ann Surg Oncol 14 1151 1160
91. R Adam G Pascal D Castaing et al 2004 Tumor progression while on chemotherapy Ann Surg 240 1052 1064
92. LA Lambert TA Colacchio RJ Barth 2000 Interval hepatic resection of colorectal metastases improves patient selection Arch Surg 135 473 479
93. H Yoshidome F Kimura H Shimizu et al 2008 Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg 12 1391 1398
94. S Kopetz JN Vauthey 2008 Perioperative chemotherapy for resectable hepatic metastases Lancet 371 963 964
95. Y Shimizu K Yasui T Sano et al 2008 Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci Langenbecks Arch Surg 393 181 184
96. G Gruenberger D Tamandl J Schueller et al 2008 Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colon cancer J Clin Oncol 26 1830 1835
97. Bouganim N, Ang C, Kavan P, et al. Perioperative bevacizumab containing chemotherapy for colorectal liver metastases. J Clin Oncol. 2008;26:abstr 15073.
98. Berry SR, Van Cutsem E, Kretzschmar A, et al. Final efficacy results for bevacizumab plus standard first-line chemotherapies in patients with metastatic colorectal cancer: first BEAT. J Clin Oncol. 2008;26:abstr 4025.
99. RR White LH Schwartz JA Munoz et al 2008 Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases J Surg Oncol 97 601 604
100. D Elias O Youssef L Sideris et al 2004 Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy J Surg Oncol 86 4 9
101. R Adam DA Wicherts RJ de Haas et al 2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 1635 1641
102. S Benoit A Brouquet C Penna et al 2006 Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 3939 3945
103. MCB Tan DC Linehan WG Hawkins et al 2007 Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathological response J Gastrointest Surg 11 1112 1119
104. Covas A, Amininejad L, Lucidi V, et al. Evaluation of the correlation of complete metabolic response with 18-FDG PET scan and complete pathologic response induced by neoadjuvant chemotherapy for colorectal liver metastases. J Clin Oncol. 2008;26:abstr 4070.
105. R Conlon M Jacobs D Dasgupta et al 2003 The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging Eur J Ultrasound 16 211 216
106. WR Jarnagin AM Bach CB Winston et al 2001 What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 192 577 583
107. SM Wildi C Gubler T Hany et al 2008 Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT J Clin Ultrasound 36 20 26
108. D Tamandl B Herberger B Gruenberger et al 2008 Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases Surgery 143 648 657
109. L Rubbia-Brandt V Audard P Sartoretti et al 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 460 466
110. M Karoui C Penna M Amin-Hashem et al 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 1 7
111. T Aloia M Sebagh M Plasse et al 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 4983 4990
112. JN Vauthey TM Pawlik D Ribero et al 2006 Chemothearpy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2065 2072
113. H Nakano E Oussoultzoglou E Rosso et al 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 118 124
114. TM Pawlik K Olino AL Gleisner et al 2007 Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 860 868
115. S Kandutsch M Klinger S Hacker et al 2008 Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases Eur J Surg Oncol 34 1231 1236
116. NN Mehta R Ravikumar CA Coldham et al 2008 Effect of preoperative chemotherapy on liver resection for colorectal liver metastases Eur J Surg Oncol 34 782 786
117. Julie C, Lutz MP, Aust D, et al. Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983. Paper presented at the 2007 Gastrointestinal Cancers Symposium, abstr 241.
118. FG Fernandez J Ritter JW Goodwin et al 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 845 853
119. SK Reddy MA Morse HI Hurwitz et al 2008 Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases J Am Coll Surg 206 96 106
120. Klinger M, Kandutsch S, Hacker S, et al. Patterns of hepatotoxicity after chemotherapy for colorectal cancer metastases. J Clin Oncol. 2008;226:abstr 4082.
121. D Ribero H Wang M Donadon et al 2007 Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer 110 2761 2767
122. Aussilhou B, Faivre S, Lepille v, et al. Preoperative bevacizumab may impair liver hypertrophy of the future remnant liver after a portal vein occlusion in patients undergoing major resections of colorectal liver metastases. J Clin Oncol. 2008;26:abstr 4081.
123. SK Reddy TM Pawlik D Zorzi et al 2007 Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis Ann Surg Oncol 14 3481 3491
124. L Capussotti A Ferrero L Vigano et al 2007 Major liver resections synchronous with colorectal surgery Ann Surg Oncol 14 195 201
125. K Tanaka H Shimada K Matsuo et al 2004 Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases Surgery 136 650 659
126. R Adam 2007 Colorectal cancer with synchronous liver metastases Br J Surg 94 129 131
127. C Ariyan D Wong Y Fong 2007 Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis (editorial) Ann Surg Oncol 14 3295 3296
128. TD Yan F Chu D Black et al 2007 Synchronous resection of colorectal primary cancer and liver metastases World J Surg 31 1496 1501
129. O Turrini F Viret J Guiramand et al 2007 Strategies for the treatment of synchronous liver metastasis Eur J Surg Oncol 33 735 740
130. A Thelen S Jonas C Benckert et al 2007 Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer Int J Colorectal Dis 22 1269 1276
131. I Vassiliou N Arkadopoulos T Theodosopoulos et al 2007 Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations World J Gastroenterol 13 1431 1434
132. JC Weber P Bachellier E Oussoultzoglou D Jaeck 2003 Simultaneous resection of colorectal primary tumour and synchronous liver metastases Br J Surg 90 956 962
133. KCMJ Peeters CAM Marijnen ID Nagtegaal et al 2007 The TME trial after a median follow-up of 6 years Ann Surg 246 693 701
134. A Martling T Holm J Johansson et al 2001 The Stockholm II Trial on preoperative radiotherapy in rectal carcinoma Cancer 92 896 902
135. J Folkesson H Birgisson v Pahlman et al 2005 Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 5644 5650
136. JF Bosset L Collette G Calais et al 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114 1123
137. Ahmed S, Shahid R, Zhu T, et al. Effect of surgical resection of primary tumor in advanced colorectal cancer (CRC) on outcome: a Canadian province's experience. J Clin Oncol. 2008;26:abstr 15016.
138. L Ruo C Gougoutas PB Paty et al 2003 Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients J Am Coll Surg 196 722 728
139. P Michel I Roque F Di Fiore et al 2004 Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 28 434 437
140. Kemeny NE, Capanu M, Fong Y, et al. Survival after resection of liver metastases from colorectal cancer with poor clinical risk factors using adjuvant systemic plus hepatic arterial therapy. J Clin Oncol. 2008;26:abstr 4076.
141. Langer B, Bleiberg H, Labianca R, et al. Fluorouracil plus I-leucovorin versus observation after potentially curative resection of liver or lung metastases from colorectal cancer. Proc Am Soc Clin Oncol. 2002;21:abstr 149a.
142. NJ Lygidakis G Sgourakis L Vlachos et al 2001 Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study Hepatogastroenterology 48 1685 1691
143. M Lorenz HH Müller H Schramm et al 1998 Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg 228 756 762
144. FKS Welsh HS Tilney PP Tekkis et al 2007 Safe liver resection following chemotherapy for colorectal liver metastases is a matter of timing Br J Cancer 96 1037 1042
145. A Sahajpal CM Vollmer E Dixon et al 2007 Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes J Surg Oncol 95 22 27
146. A Tocchi G Mazzoni S Brozzetti et al 2004 Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome Int J Colorectal Dis 19 580 585
147. D Jaeck P Bachellier JC Weber et al 1999 Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients Chirurgie 124 258 263
148. E Jovine F Biolchini F Talarico et al 2007 Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis 9 245 252
149. M Stojanović G Stanojević M Radojković et al 2008 Safety of simultaneous colon and liver resection for colorectal liver metastases Vojnosanit Pregl 65 153 157
150. Zhang HZ, Dong SX, Zhou ZX, et al. Simultaneous liver and colorectal resection for synchronous colorectal liver metastasis. Zhonghua Wai Ke Za Zhi. 2007;45902-4.
151. N Taniai H Yoshida Y Mamada et al 2006 Outcome of surgical treatment of synchronous liver metastases from colorectal cancer J Nippon Med Sch 73 82 88
152. H Sasanuma Y Yasuda FV Mortensen et al 2006 Simultaneous colorectal and liver resections for synchronous colorectal metastases Scand J Surg 95 176 179
153. HK Chua K Sondenaa GG Tsiotos et al 2004 Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases Dis Colon Rectum 47 1310 1316
154. R Martin P Paty Y Fong et al 2003 Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases J Am Coll Surg 197 233 242
155. S Lyass G Zamir I Matot et al 2001 Combined colon and hepatic resection for synchronous colorectal liver metastases J Surg Oncol 78 17 21
156. S Fujita T Akasu Y Moriya 2000 Resection of synchronous liver metastases from colorectal cancer Jpn J Clin Oncol 30 7 11
157. Y Sugawara J Yamamoto S Yamasaki et al 2001 Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy Surgery 129 408 413
158. JS Bolton GM Fuhrman 2000 Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma Ann Surg 231 743 751
159. M Doko M Zovak M Ledinsky et al 2000 Safety of simultaneous resections of colorectal cancer and liver metastases Coll Antropol 24 381 390
160. J Scheele R Stangl A Altendorf-Hofmann et al 1991 Indicators of prognosis after hepatic resection for colorectal secondaries Surgery 110 13 29
161. P Vogt R Raab B Ringe R Pichlmayr 1991 Resection of synchronous liver metastases from colorectal cancer World J Surg 15 62 67
162. G Jatzko V Wette M Muller et al 1991 Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital Int J Colorect Dis 6 111 114